An Overview of the 2022 Update of Good Publication Practice (GPP) Guidelines: A Medical Writer’s Perspective

Authors

  • Qing Zhou, PhD, ELS Regeneron Pharmaceuticals, Inc, Tarrytown, NY

DOI:

https://doi.org/10.55752/amwa.2023.263

Abstract

This year marks the 20-year anniversary of the Good Publication Practice (GPP) guidelines, a set of principles and recommendations pertaining to peer-reviewed or peerorientated publications arising from research funded by or conducted in collaboration with industry sponsors. Since the publication in the initial GPP guidelines in 2003, GPP guidelines have undergone several updates, with the latest iteration (GPP 2022 update) published in August 2022. The latest GPP guidelines built upon prior work and continue to strengthen principles and refine practices to reflect a rapidly evolving field of biomedical publishing. This article summarizes what is new in the latest GPP update and provide a quick document tour to help readers navigate the GPP 2022 document. In addition, a section from the perspective from medical writers and editors provides a preview of principles and practical guidance relevant to our day-to-day work. It is expected that further dissemination and discussion of the latest GPP 2022 update will continue to take place among publication professionals, medical writers, authors, journal editors and publishers, and other stakeholders, who share common goals of transparency, accountability, and quality of publications arising from company-sponsored biomedical research.

Published

2023-06-06

How to Cite

1.
Zhou Q. An Overview of the 2022 Update of Good Publication Practice (GPP) Guidelines: A Medical Writer’s Perspective. AMWA. 2023;38(2). doi:10.55752/amwa.2023.263

Issue

Section

Theme Articles